Thanks Eire.
I'd like to know when we expect to start the phase 2 EFS study in the US, how many patients do we expect to enroll and what's an estimated time to get results (not including the long-term follow-up obviously). And will the phase 2 completion give us enough data to submit the application for Premarket Approval.
Thanks Eire.I'd like to know when we expect to start the phase 2...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |